Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-05-09 Purchase | 2025-05-13 8:05 pm | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 9,510 | $105.2 | $1,000,456 | 161,234 (Direct) | View |
| 2024-08-08 Purchase | 2024-08-09 5:52 pm | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 2,500 | $97.39 | $243,481 | 123,010 (Direct) | View |
| 2023-09-22 Purchase | 2023-09-25 4:44 pm | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER | 4,000 | $59.38 | $237,529 | 73,090 (Direct) | View |
| 2021-02-10 Sale | 2021-02-12 6:23 pm | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 5,083 | $213.14 | $1,083,410 | 50,152 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-07-02 Option Award | 2025-07-07 9:43 pm | 2026-07-02 2035-07-02 | Pelthos Therapeutics Inc. | PTHS | Davis Todd C Director | 77,338 | $0 | 95,199 (Direct) | View |
| 2025-07-01 Conversion | 2025-07-03 9:02 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Davis Todd C Director 10% Owner | 1,500,000 | $10 | 4,633,785 (Indirect) | View |
| 2025-07-01 Conversion | 2025-07-03 9:02 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Davis Todd C Director 10% Owner | 15,000 | $0 | 4,633,785 (Indirect) | View |
| 2025-07-01 Other | 2025-07-03 9:02 pm | N/A N/A | Pelthos Therapeutics Inc. | PTHS | Davis Todd C Director 10% Owner | 31,279 | $0 | 4,633,785 (Indirect) | View |
| 2025-06-30 Other | 2025-07-02 7:31 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 233 | $91.08 | 161,700 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-11 7:59 pm | 2026-06-10 2035-06-10 | PALVELLA THERAPEUTICS INC. | PVLA | Davis Todd C Director | 12,350 | $0 | 12,350 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 6:54 pm | N/A 2035-03-04 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 114,858 | $0 | 245,200 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 8:44 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 13,452 | $120 | 130,342 (Direct) | View |
| 2025-02-14 Option Award | 2025-02-19 8:44 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 20,784 | $0 | 130,342 (Direct) | View |
| 2024-12-13 Option Award | 2024-12-17 8:44 pm | N/A 2034-12-13 | PALVELLA THERAPEUTICS INC. | PVLA | Davis Todd C Director | 24,700 | $0 | 24,700 (Direct) | View |
Ownership | 2024-12-16 7:41 pm | N/A N/A | PALVELLA THERAPEUTICS INC. | PVLA | Davis Todd C Director | 0 | $0 | 128,651 (Direct) | View |
| 2024-11-13 Option Award | 2024-11-15 4:22 pm | N/A 2024-11-13 | Chromocell Therapeutics Corp | CHRO | Davis Todd C Director | 49,605 | $0 | 263,306 (Direct) | View |
| 2024-06-28 Other | 2024-07-02 7:44 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 350 | $60.71 | 120,860 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 8:00 pm | N/A 2034-06-14 | Chromocell Therapeutics Corp | CHRO | Davis Todd C Director | 128,977 | $0 | 213,701 (Direct) | View |
| 2024-03-25 Exercise | 2024-03-27 5:47 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 3,556 | $66.19 | 120,160 (Direct) | View |
| 2024-03-25 Exercise | 2024-03-27 5:47 pm | N/A 2032-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 16,015 | $0 | 120,160 (Direct) | View |
| 2024-03-25 Exercise | 2024-03-27 5:47 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 2,855 | $67.24 | 120,160 (Direct) | View |
| 2024-03-25 Exercise | 2024-03-27 5:47 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 2,156 | $68.51 | 120,160 (Direct) | View |
| 2024-03-25 Exercise | 2024-03-27 5:47 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 7,448 | $46.2 | 120,160 (Direct) | View |
| 2024-02-27 Option Award | 2024-02-29 6:49 pm | N/A 2034-02-27 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER | 164,159 | $0 | 235,868 (Direct) | View |
| 2024-02-21 Exercise | 2024-02-23 5:15 pm | N/A N/A | Chromocell Therapeutics Corp | CHRO | Davis Todd C Director | 29,167 | $4.8 | 29,167 (Direct) | View |
| 2024-02-21 Conversion | 2024-02-23 5:15 pm | 2024-02-21 2024-02-29 | Chromocell Therapeutics Corp | CHRO | Davis Todd C Director | 175,000 | $0 | 29,167 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-16 8:10 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER | 1,381 | $74.65 | 71,709 (Direct) | View |
Ownership | 2024-02-15 8:02 pm | N/A 2023-12-31 | Chromocell Therapeutics Corp | CHRO | Davis Todd C Director | 0 | $0 | 230,557 (Direct) | View |
| 2023-06-09 Tax Withholding | 2023-06-13 6:52 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER | 420 | $73.76 | 69,090 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 8:50 pm | N/A 2033-02-23 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 63,183 | $0 | 114,969 (Direct) | View |
| 2022-12-22 Option Award | 2022-12-27 6:26 pm | N/A 2032-12-22 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 2,081 | $0 | 2,081 (Direct) | View |
| 2022-12-05 Option Award | 2022-12-06 8:25 pm | N/A 2032-12-05 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 132,000 | $0 | 132,000 (Direct) | View |
| 2022-08-04 Option Award | 2022-08-08 6:26 pm | N/A 2032-08-03 | Vaxart Inc. | VXRT | Davis Todd C Director | 51,599 | $0 | 170,129 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 6:46 pm | N/A 2032-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 5,344 | $0 | 56,126 (Direct) | View |
| 2022-03-22 Other | 2022-03-22 5:12 pm | N/A N/A | BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Davis Todd C Director | 252,207 | $0 | 252,207 (Direct) | View |
| 2022-01-27 Exercise | 2022-02-01 4:06 pm | N/A 2023-01-27 | BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Davis Todd C Director | 7,684 | $0 | 361,021 (Direct) | View |
| 2022-01-27 Option Award | 2022-02-01 4:06 pm | N/A 2023-01-27 | BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Davis Todd C Director | 15,369 | $0 | 361,021 (Direct) | View |
| 2022-01-27 Option Award | 2022-02-01 4:06 pm | N/A 2032-01-26 | BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Davis Todd C Director | 85,760 | $3.66 | 361,021 (Direct) | View |
| 2021-12-22 Gift | 2021-12-23 6:07 pm | N/A N/A | Vaxart Inc. | VXRT | Davis Todd C Director | 1,470 | $0 | 118,530 (Direct) | View |
| 2021-08-06 Exercise | 2021-08-10 6:15 pm | N/A 2022-08-01 | BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Davis Todd C Director | 30,000 | $0 | 259,523 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 7:25 pm | N/A 2031-06-15 | Vaxart Inc. | VXRT | Davis Todd C Director | 15,097 | $0 | 15,097 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-07 9:25 pm | N/A 2031-06-04 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 3,899 | $0 | 54,051 (Direct) | View |
| 2018-12-26 Ownership | 2021-02-16 4:02 pm | N/A N/A | BIODELIVERY SCIENCES INTERNATIONAL INC | BDSI | Davis Todd C Director | 3,391 | $0 | 214,523 (Direct) | View |
| 2021-02-11 Exercise | 2021-02-12 6:23 pm | N/A 2028-06-18 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 2,474 | $0 | 50,152 (Direct) | View |
| 2021-02-11 Exercise | 2021-02-12 6:23 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 2,474 | $195.91 | 50,152 (Direct) | View |
| 2021-01-27 Exercise | 2021-01-27 7:02 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 2,456 | $113.5 | 52,761 (Direct) | View |
| 2021-01-27 Exercise | 2021-01-27 7:02 pm | N/A 2027-05-25 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 2,456 | $0 | 52,761 (Direct) | View |